[5] While GLP-1 receptor agonists should not be prescribed solely for cholesterol lowering, certain patient populations may derive particular benefit from their lipid and broader cardiometabolic effects
For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
Price: $179 first month $299/month after Option 2: Daily Dissolvable Tablet (Compounded Semaglutide or Tirzepatide) Same active ingredients as the injection, just no needles
For some individuals, the risks of stopping abruptly may outweigh the potential risks of continuing